ALLTRACEL pharmaceuticals has announced plans to splash out up to €8 million for a London-based specialist dental care company.

IRELAND Inc is open for business, Enterprise Trade and Employment Minister Micheál Martin told Japanese business leaders last night.

FIRST AID product developer Alltracel Pharmaceuticals remained on track to meet analysts forecasts when it reported strong third-quarter revenues of €0.7 million yesterday, up from €0.1 million in the same period last year.

SHARES in Alltracel Pharmaceuticals rose more than 2% yesterday after the fledgling Dublin-based first aid product developer completed a €6.8 million fundraising round.

ALLTRACEL Pharmaceuticals founder and chief executive Gerry Brandon is to step down, the first aid product developer said yesterday.

SHARES in Alltracel Pharmaceuticals rose by 6% yesterday after the fledgling Dublin-based first aid product developer announced two major deals with leading names in the industry.

Alltracel Pharmaceuticals said its first quarter revenue was €857,000, up 340% over first quarter 2003 revenues and more than double last quarter’s record revenue result.

A KENMARE company that sells hotel rooms over the internet hopes to raise up to $80 million (€65 million) when it floats on the London stock exchange next month.

THE bell tolls for First Active’s short life as a publicly-quoted company tomorrow.

A CORK drug research company will complete its journey from UCC start-up to the London Stock Exchange early next month.

ALLTRACEL Pharmaceuticals, the Dublin-based manufacturer of anti-bleeding and wound-care products, will continue its strong share price momentum, according to research published last week by Davy stockbrokers.